Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with &lt;i&gt;PIK3CA&lt;/i&gt;-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study. The gene discussed is PIK3CA; the disease is breast carcinoma.